Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 22

1569P - The CODRP model for predicting drug sensitivity in patient-derived 3D gastric cancer cells

Date

21 Oct 2023

Session

Poster session 22

Topics

Cancer Biology;  Cell-Based Therapy;  Cancer Diagnostics;  Cancer Research

Tumour Site

Gastric Cancer

Presenters

Dong Woo Lee

Citation

Annals of Oncology (2023) 34 (suppl_2): S852-S886. 10.1016/S0923-7534(23)01930-0

Authors

D.W. Lee1, I.H. Kim2, J. LEE3, S.H. Yun2, B. Ku4, S. LEE3, M. YOO3, D. SEOL3, T. LEE3, E. LEE3, D. HWANG3, S.H. KANG3, Y.S. PARK3, J. Kim5, J.W. Kim5, S. AHN3, K. Lee5, H. KIM3, H. OH6, Y. SUH3

Author affiliations

  • 1 Biomedical Engineering, Gachon University - Global Campus, 13120 - Seongnam/KR
  • 2 Precision Medicine Research, MBD Co., Ltd, 16229 - Suwon/KR
  • 3 Surgery, Seoul National University Bundang Hospital, 463-707 - Seongnam/KR
  • 4 Chief Executive Officer, MBD Co., Ltd, 16229 - Suwon/KR
  • 5 Internal Medicine, Seoul National University Bundang Hospital, 463-707 - Seongnam/KR
  • 6 Pathology, Seoul National University Bundang Hospital, 463-707 - Seongnam/KR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1569P

Background

Recently, cancer organoid-based drug sensitivity tests have been studied to predict patient responses to anticancer drugs. This study proposes a multi-factor analysis method (cancer organoid-based diagnosis reactivity prediction, CODRP) that considers the cancer stage and cancer cell growth rate, which represent the severity of cancer patients, in the sensitivity test for gastric cancer patients.

Methods

Primary cells were isolated from surgical tissues from 143 gastric cancer (GC) patients and mixed with matrigel to make patient derived 3D cultured cells. Due to small number of patient’s cells, we used 384 pillar plate (MBD, Korea) for high throughput screening. 1.5ul spots dispensed on pillar and, the cells were stabilized in a culture medium optimized for GC cells for 3days and the drug response was observed for 7days. 3D cell morphology was scanned after calcein staining and cell viability was quantified using ATP assay. The primary characteristics of GC 3D cultured cells were confirmed by IHC. The drug responses were calculated by a sigmoidal dose response curve and compared to clinical case report form.

Results

Evaluation of drug response was established for various drugs in 143 patients and success rate was 71%. We analyzed drug response through CODRP analysis method using multi-factor (cell growth rate, TNM stage, AUC). In clinic, 56 patients were treated by oxaliplatin after surgery, the CODRP index about oxaliplatin compared with clinical response. Although the clinical recurrence rate was low due to the 1 year follow up, the early recurrence rate by CODRP analysis in the resistant group was 10%p higher than AUC analysis, while there was almost no difference in the sensitive group. When we analyze the 1-year recurrence-free survival rate in the CODRP model, the sensitive group showed 78% survival, while the resistant group showed 38.2% survival. Therefore, there was a significant difference in 1 year recurrence-free survival rate based on the CODRP model.

Conclusions

This study proposes a novel drug sensitivity prediction model using patient derived 3D cultured cells. In 56 gastric cancer patients, CODRP models based on the drug sensitivity AUC, growth rate, and cancer stage successfully predict clinical response of patient’s drug treatment.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

MBD.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.